Tindog, Sharlipa May Y.

HRN: 03-63-17  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2025
AMPICILLIN 1GM (VIAL)
08/12/2025
08/19/2025
IVT
2gms
Q6
PROM, MSAF
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: